Anitra W. Romfh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anitra W. Romfh has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Doff B. McElhinney
Stanford University School of Medicine, Palo Alto, California, USA
3 shared publications - Christiane Haeffele
Stanford University, Stanford, California, USA
2 shared publications - George K. Lui
Stanford University School of Medicine
2 shared publications - Sumeet S. Vaikunth
Internal Medicine and Pediatrics, Hospital of the University of Pennsylvania, Philadelphia (S.S.V.).
2 shared publications Abigail Khan
Oregon Health and Science University
1 shared publication- Anne C. Taylor
Department of Pediatrics, Pediatric Cardiology (J.K.Y., L.W., A.C.T., H.C., A.W.R., L.F.P., S.R.C., A.M.D., D.B.M.), Stanford University, Palo Alto, CA
1 shared publication
Latest Publications
- Open Access
- 5 August 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (15) , e043295
Unlocking Potential: The Untapped Resources to Expand the Field of Adult Congenital Heart Disease Providers
- 5 August 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (15) , e043295
Open AccessUnlocking Potential: The Untapped Resources to Expand the Field of Adult Congenital Heart Disease Providers
- 1 January 2025
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 18 (1) , e014381
Extended Rhythm Monitoring to Assess for Ventricular Arrhythmias After Transcatheter Pulmonary Valve Replacement With the Harmony Valve
BACKGROUND: Varying rates of nonsustained ventricular tachycardia (NSVT) have been reported early after transcatheter pulmonary valve replacement (TPVR) with the Harmony valve, but data regarding rhythm outcomes beyond hospital discharge are limited. This study aims to characterize ventricular arrhythmias after Harmony TPVR from implant through mid-term follow-up. METHODS: Ventricular arrhythmia data from postimplant telemetry and follow-up extended rhythm monitoring (ERM) were analyzed after Harmony TPVR. RESULTS: Fifty-four patients with tetralogy of Fallot (n=39), valvar pulmonary stenosis (n=10), or pulmonary atresia with intact ventricular septum (n=5) were studied; 22% had prior NSVT and 24% were on prior rhythm medication. On postimplant telemetry, 27 patients (50%) had NSVT, including 1 who had torsade de pointes, but most had <5 episodes. Pre-TPVR NSVT or rhythm medications, diagnosis other than tetralogy, and substantial device contact with the myocardium were associated with more frequent NSVT on telemetry. Ten patients (19%) were started on a new antiarrhythmic medication. On discharge ERM, 37% of patients had NSVT, most with <5 episodes and only 13% with NSVT beyond 5 days post-discharge. On follow-up ERM, 14% of patients had a single episode of NSVT and 1 had 5 episodes. During follow-up, antiarrhythmic medications were discontinued in 8 of 10 patients and no patients died or had sustained ventricular tachycardia. CONCLUSIONS: NSVT and ventricular ectopy were common early after TPVR but were infrequent in most cases and diminished rapidly after discharge. The incidence of NSVT on follow-up ERM was similar to preimplant incidence. Few patients had antiarrhythmic medications initiated, and most were discontinued on follow-up. There were no major arrhythmic events after discharge.
- 1 January 2025
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 18 (1) , e014381
Extended Rhythm Monitoring to Assess for Ventricular Arrhythmias After Transcatheter Pulmonary Valve Replacement With the Harmony Valve
BACKGROUND: Varying rates of nonsustained ventricular tachycardia (NSVT) have been reported early after transcatheter pulmonary valve replacement (TPVR) with the Harmony valve, but data regarding rhythm outcomes beyond hospital discharge are limited. This study aims to characterize ventricular arrhythmias after Harmony TPVR from implant through mid-term follow-up. METHODS: Ventricular arrhythmia data from postimplant telemetry and follow-up extended rhythm monitoring (ERM) were analyzed after Harmony TPVR. RESULTS: Fifty-four patients with tetralogy of Fallot (n=39), valvar pulmonary stenosis (n=10), or pulmonary atresia with intact ventricular septum (n=5) were studied; 22% had prior NSVT and 24% were on prior rhythm medication. On postimplant telemetry, 27 patients (50%) had NSVT, including 1 who had torsade de pointes, but most had <5 episodes. Pre-TPVR NSVT or rhythm medications, diagnosis other than tetralogy, and substantial device contact with the myocardium were associated with more frequent NSVT on telemetry. Ten patients (19%) were started on a new antiarrhythmic medication. On discharge ERM, 37% of patients had NSVT, most with <5 episodes and only 13% with NSVT beyond 5 days post-discharge. On follow-up ERM, 14% of patients had a single episode of NSVT and 1 had 5 episodes. During follow-up, antiarrhythmic medications were discontinued in 8 of 10 patients and no patients died or had sustained ventricular tachycardia. CONCLUSIONS: NSVT and ventricular ectopy were common early after TPVR but were infrequent in most cases and diminished rapidly after discharge. The incidence of NSVT on follow-up ERM was similar to preimplant incidence. Few patients had antiarrhythmic medications initiated, and most were discontinued on follow-up. There were no major arrhythmic events after discharge.
- Open Access
- 1 October 2021
- Published by Elsevier in International Journal of Cardiology Congenital Heart Disease
- Vol. 5, 100223
Erratum to “The atrial switch patient with a dilated subpulmonic left ventricle” [Int. J. Cardiol. Congenit. Heart Dis. 4 (August 2021) 100153]
- 1 October 2021
- Published by Elsevier in International Journal of Cardiology Congenital Heart Disease
- Vol. 5, 100223
Open AccessErratum to “The atrial switch patient with a dilated subpulmonic left ventricle” [Int. J. Cardiol. Congenit. Heart Dis. 4 (August 2021) 100153]
- Open Access
- 15 May 2021
- Published by Elsevier in International Journal of Cardiology Congenital Heart Disease
- Vol. 4, 100153
The atrial switch patient with a dilated subpulmonic left ventricle
- 15 May 2021
- Published by Elsevier in International Journal of Cardiology Congenital Heart Disease
- Vol. 4, 100153
Open AccessThe atrial switch patient with a dilated subpulmonic left ventricle